VANCOUVER, British Columbia — The use of dexamethasone intravitreal implantation improved uveitic macular edema and the corresponding reduced visual acuity in patients who were pseudophakic or about to undergo cataract surgery.
Lead author Grace Levy-Clarke, MD, of Tampa Bay Uveitis Center, St. Petersburg, Florida, presented the study results here at the Association for Research in Vision and Ophthalmology meeting.
“For those of us who manage a lot of uveitis patients, the holy grail is patients who develop uveitic glaucoma and patients who develop uveitic macular edema,”
Uncategorized